Search - tctmd.com

Displaying 1 - 20 of 57

Sort: Relevancy | Date

Presentation TCT 2016

FFR in the setting of CABG and AS/AVR/TAVR

Presenter: Bernard De Bruyne, Allen Jeremias, Emanuele Barbato

November 01, 2016

Presentation TCT 2016

Non-Hyperemic Indices: Glossary and Clinical Outcome Data

Presenter: Bernard De Bruyne, Allen Jeremias

November 01, 2016

Presentation TCT 2016

Standardization of FFR Acquisition and Storage

Presenter: Bernard De Bruyne, Allen Jeremias

November 01, 2016

Presentation TCT 2016

IMPACT: Randomized Evaluation of a Rapid Exchange FFR Microcatheter in Intermediate Coronary Stenoses

Presenter: Bernard De Bruyne, Allen Jeremias, Tim P. van de Hoef

November 01, 2016

Presentation TCT 2016

Standard and Novel Pressure Measuring Devices: Differences, Similarities, and Practical Recommendations

Presenter: Bernard De Bruyne, Allen Jeremias, Morton J. Kern

November 01, 2016

Presentation TCT 2016

Routine FFR at the Time of Diagnostic Angiography - Ready for Primetime?

Presenter: Allen Jeremias, Nico H.J. Pijls, Nick Curzen

October 31, 2016

Presentation TCT 2016

Post-PCI FFR Measurements: Lessons From FAME I and II

Presenter: Allen Jeremias, Nico H.J. Pijls, Zsolt Piroth

October 31, 2016

Presentation TCT 2016

Contrast as a Hyperemic Agent: Easier, but Sufficient?

Presenter: Allen Jeremias, Nico H.J. Pijls, Nils Johnson

October 31, 2016

Presentation TCT 2016

FFR and CFR: Similarities, Differences, and When to Prefer Each

Presenter: Allen Jeremias, Nico H.J. Pijls, Tim P. van de Hoef

October 31, 2016

Presentation TCT 2016

Coronary Pathophysiology and FFR

Presenter: Peter Barlis, Grzegorz L. Kaluza, Allen Jeremias

October 29, 2016

Presentation Fellows 2016

Case 1

Presenter: Gary S. Mintz, Allen Jeremias

April 16, 2016

Presentation Fellows 2016

Physiologic Lesion Assessment in the Cath Lab

Presenter: Gary S. Mintz, Allen Jeremias

April 16, 2016

Presentation Fellows 2016

Case 1: Dilemmas in DAPT and PCI Pharmacology

Presenter: Allen Jeremias

April 15, 2016

Presentation Intravascular Coronary Imaging and Physiology 2016

How Do I Assess an Intermediate Lesion?

Presenter: Allen Jeremias

March 11, 2016

Presentation Intravascular Coronary Imaging and Physiology 2016

Physiologic Lesion Assessment Improves Patient Outcomes

Presenter: Allen Jeremias

March 10, 2016

Presentation TCT 2015

Novel Hyperemic Agents (Regadenoson, Nicorandil, and Nitroprusside)

Presenter: Allen Jeremias, Nils Johnson, Habib Samady

October 12, 2015

Presentation TCT 2015

Left Main Disease: When to Use FFR vs IVUS

Presenter: Allen Jeremias, Nils Johnson, William F. Fearon

October 12, 2015

Presentation TCT 2015

Intracoronary Physiology in NSTEMI and STEMI: Is Accurate Lesion Assessment Possible?

Presenter: Allen Jeremias, Nils Johnson, Colin Berry

October 12, 2015

Presentation TCT 2015

Fifteen-Year DEFER and 5-Year FAME Outcomes

Presenter: Allen Jeremias, Nils Johnson, Nico H.J. Pijls

October 12, 2015

Presentation TCT 2015

Nonhyperemic Indices of Stenosis Severity: Ready for Prime Time?

Presenter: Justin E. Davies, Bernard De Bruyne, Allen Jeremias

October 12, 2015

Advertisement

FFR in the setting of CABG and AS/AVR/TAVR

Non-Hyperemic Indices: Glossary and Clinical Outcome Data

Standardization of FFR Acquisition and Storage

IMPACT: Randomized Evaluation of a Rapid Exchange FFR Microcatheter in Intermediate Coronary Stenoses

Standard and Novel Pressure Measuring Devices: Differences, Similarities, and Practical Recommendations

Routine FFR at the Time of Diagnostic Angiography - Ready for Primetime?

Post-PCI FFR Measurements: Lessons From FAME I and II

Contrast as a Hyperemic Agent: Easier, but Sufficient?

FFR and CFR: Similarities, Differences, and When to Prefer Each

Coronary Pathophysiology and FFR

Case 1

Physiologic Lesion Assessment in the Cath Lab

Case 1: Dilemmas in DAPT and PCI Pharmacology

How Do I Assess an Intermediate Lesion?

Physiologic Lesion Assessment Improves Patient Outcomes

Novel Hyperemic Agents (Regadenoson, Nicorandil, and Nitroprusside)

Left Main Disease: When to Use FFR vs IVUS

Intracoronary Physiology in NSTEMI and STEMI: Is Accurate Lesion Assessment Possible?

Fifteen-Year DEFER and 5-Year FAME Outcomes

Nonhyperemic Indices of Stenosis Severity: Ready for Prime Time?

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content